Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Patent symbols : Nvs save search
Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published: 2024-02-15 (Crawled : 23:00) - prnewswire.com
TRUMF | $16.608 -17.59% 5.6K
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: -3.21%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: -1.59%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: -1.04%
TRUMY | $17.05 0.79% 47K
|
Manufacturing
|
| O: 0.27%
H: 0.0%
C: -2.6%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.37%
H: 0.57%
C: 0.19%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.83%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
drug patent report review global advanced market
Biosimilars Market Research Report 2023 - Global Forecast to 2028 - Patent Expiries of Blockbuster Biologics and Research into New Indications Presents Opportunities
Published: 2023-07-05 (Crawled : 00:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.17%
H: 0.63%
C: 0.22%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.55%
H: 0.97%
C: 0.02%
AMRX | $6.07 12.41% 11.04% 3.1M
|
Health Technology
|
| O: -2.54%
H: 10.78%
C: 10.04%
AMPH | $40.98 0.17% 0.17% 220K
|
Health Technology
|
| O: -0.52%
H: 1.38%
C: -0.38%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.43%
H: 0.48%
C: -0.86%
patent report research global market
Global Type 2 Diabetes Treatment Market Outlook Report 2022-2023 & 2027: Patent Cliff, Oral Antidiabetics, and Growing Focus on Accessibility and Affordability of Medicine Bolsters Growth
Published: 2023-01-04 (Crawled : 23:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -0.93%
H: 3.08%
C: 3.08%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.89%
H: 1.18%
C: 0.52%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.85%
H: 0.2%
C: -0.29%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.62%
H: 0.54%
C: -0.12%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -3.07%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.49%
H: 1.65%
C: 0.94%
treatment patent global report growing diabetes growth market
Novartis plans to petition the U.S. Supreme Court to uphold validity of the Gilenya® (fingolimod) dosing regimen patent
Published: 2022-09-21 (Crawled : 06:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.98%
H: 0.0%
C: -1.99%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.73%
H: 0.04%
C: -1.85%
gilenya patent novartis
Novartis statement regarding competition authority investigation into assertion of a patent
Published: 2022-09-15 (Crawled : 06:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.12%
H: 0.66%
C: -0.09%
patent novartis
Novartis plans to petition the U.S. Court of Appeals for the Federal Circuit for further review to uphold validity of the Gilenya® (fingolimod) dosing regimen patent
Published: 2022-06-21 (Crawled : 20:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.57%
H: 0.0%
C: 0.0%
gilenya patent novartis review
Immutep Announces Second Japanese Patent Grant for LAG-3 Antagonist Antibody LAG525
Published: 2022-03-18 (Crawled : 12:30) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.17%
H: 1.2%
C: 1.01%
IMMP | $2.59 3.19% 3.09% 1.4M
|
Health Technology
|
| O: 3.31%
H: 11.74%
C: 10.32%
lag525 patent antibody grant granted
Novartis announces U.S. Court of Appeals for the Federal Circuit (CAFC) upholds validity of Gilenya® (fingolimod) dosage regimen patent
Published: 2022-01-04 (Crawled : 07:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.17%
H: 0.12%
C: -0.62%
gilenya novartis als patent
Defence Therapeutics Files Acid-Based Hydrogels USA Provisional Patent Application
Published: 2021-08-31 (Crawled : 14:00) - biospace.com/
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.47%
H: 0.7%
C: -0.66%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.1%
H: 0.58%
C: -0.21%
MMM | $92.02 -1.05% 0.0% 3.8M
|
Producer Manufacturing
|
| O: -0.16%
H: 0.07%
C: -0.57%
patent defense application therapeutics
Immutep Announces Chinese Patent Grant for LAG-3 Antagonist Antibody LAG525
Published: 2021-08-27 (Crawled : 12:15) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
IMMP | $2.59 3.19% 3.09% 1.4M
|
Health Technology
|
| O: 1.39%
H: 2.73%
C: 2.46%
chinese antibody patent granted grant
Global $191 Billion Orphan Drugs Markets to 2026: Therapeutic Applications in Rare and Orphan Diseases, Regulatory Framework, Patents, and Innovations
Published: 2021-08-05 (Crawled : 20:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.85%
H: 0.15%
C: -0.16%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -2.02%
H: 0.09%
C: -1.38%
disease drug patent application rare
Global Drug Delivery Systems (DDS) Markets 2021-2027 - Increasing R&D Expenditures of Innovator Companies and the Trend of Patent Portfolio Expansion
Published: 2021-07-29 (Crawled : 15:15) - prnewswire.com
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: 0.62%
H: 0.73%
C: 0.42%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.74%
H: 0.22%
C: -0.41%
CTLT | $55.95 -0.14% 0.0% 2M
|
Health Technology
|
| O: 0.23%
H: 2.96%
C: 2.18%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.4%
H: 0.08%
C: -0.13%
TFFP | $3.04 2.36% 2.3% 13K
|
Health Technology
|
| O: 2.89%
H: 0.0%
C: -1.57%
LGND | $70.87 1.4% 1.38% 150K
|
Health Technology
|
| O: -0.09%
H: 1.78%
C: -3.55%
HALO 4 | $39.095 0.32% 0.32% 620K
|
Health Technology
|
| O: 0.34%
H: 1.37%
C: -1.63%
ARCT 4 | $27.0 -3.33% -3.44% 270K
|
Health Technology
|
| O: -0.06%
H: 1.09%
C: -6.17%
AQST | $3.905 -8.76% -9.6% 2.1M
|
Health Technology
|
| O: 0.57%
H: 1.7%
C: -2.27%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.09%
H: 0.29%
C: -0.82%
expansion drug patent drug delivery liver
Immutep Announces European Patent Grant For LAG525 Antibody In Combination Therapy
Published: 2021-04-07 (Crawled : 12:15) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.02%
H: 0.34%
C: -0.09%
IMMP | $2.59 3.19% 3.09% 1.4M
|
Health Technology
|
| O: 3.31%
H: 5.77%
C: 1.92%
therapy antibody patent imp701 granted grant
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.